vlog

[Skip to Navigation]
Sign In
Table 1. Participant Demographic and Clinical Characteristics by ADI Quintile and Ethnicity
Table 2. Linear Regression Analysis for Older Mexican American Adultsa
Table 3. Linear Regression Analysis for Older Non-Hispanic White Adultsa
1.
Matthews KA, Xu W, Gaglioti AH, et al. Racial and ethnic estimates of Alzheimer’s disease and related dementias in the United States (2015-2060) in adults aged ≥65 years. Alzheimers Dement. 2019;15(1):17-24. doi:
2.
QuickFacts. United States Census Bureau; 2020. Accessed February 16, 2022.
3.
Babulal GM, Quiroz YT, Albensi BC, et al; International Society to Advance Alzheimer’s Research and Treatment, Alzheimer’s Association. Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: update and areas of immediate need. Alzheimers Dement. 2019;15(2):292-312. doi:
4.
Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995:80-94. doi:
5.
Vega IE, Cabrera LY, Wygant CM, Velez-Ortiz D, Counts SE. Alzheimer’s disease in the Latino community: intersection of genetics and social determinants of health. J Alzheimers Dis. 2017;58(4):979-992. doi:
6.
Alson JG, Robinson WR, Pittman L, Doll KM. Incorporating measures of structural racism into population studies of reproductive health in the United States: a narrative review. Health Equity. 2021;5(1):49-58. doi:
7.
Erikson CE, Dent RB, Park YH, Luo Q. Historic redlining and contemporary behavioral health workforce disparities. JAMA Netw Open. 2022;5(4):e229494. doi:
8.
Johnson AE, Zhu J, Garrard W, et al. Area Deprivation Index and cardiac readmissions: evaluating risk-prediction in an electronic health record. J Am Heart Assoc. 2021;10(13):e020466. doi:
9.
Kitchen C, Hatef E, Chang HY, Weiner JP, Kharrazi H. Assessing the association between Area Deprivation Index on COVID-19 prevalence: a contrast between rural and urban U.S. jurisdictions. AIMS Public Health. 2021;8(3):519-530. doi:
10.
Singh GK. Area deprivation and widening inequalities in US mortality, 1969-1998. Am J Public Health. 2003;93(7):1137-1143. doi:
11.
Zuelsdorff M, Larson JL, Hunt JFV, et al. The Area Deprivation Index: a novel tool for harmonizable risk assessment in Alzheimer’s disease research. Alzheimers Dement (N Y). 2020;6(1):e12039. doi:
12.
Gaglioti AH, Xu J, Rollins L, et al. Neighborhood environmental health and premature death from cardiovascular disease. Prev Chronic Dis. 2018;15:E17. doi:
13.
Diez Roux AV, Mujahid MS, Hirsch JA, Moore K, Moore LV. The impact of neighborhoods on CV risk. Glob Heart. 2016;11(3):353-363. doi:
14.
Barber S, Hickson DA, Wang X, Sims M, Nelson C, Diez-Roux AV. Neighborhood disadvantage, poor social conditions, and cardiovascular disease incidence among African American adults in the Jackson Heart Study. Am J Public Health. 2016;106(12):2219-2226. doi:
15.
Xiao YYK, Graham G. Where we live: the impact of neighborhoods and community factors on cardiovascular health in the United States. Clin Cardiol. 2019;42(1):184-189. doi:
16.
Yaffe K, Falvey C, Harris TB, et al; Health ABC Study. Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study. Ѵ. 2013;347:f7051. doi:
17.
Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible—the Neighborhood Atlas. N Engl J Med. 2018;378(26):2456-2458. doi:
18.
Kind AJH, Jencks S, Brock J, et al. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med. 2014;161(11):765-774. doi:
19.
Hunt JFV, Vogt NM, Jonaitis EM, et al. Association of neighborhood context, cognitive decline, and cortical change in an unimpaired cohort. ܰDZDz. 2021;96(20):e2500-e2512. doi:
20.
Hunt JFV, Buckingham W, Kim AJ, et al. Association of neighborhood-level disadvantage with cerebral and hippocampal volume. JAMA Neurol. 2020;77(4):451-460. doi:
21.
Powell WR, Buckingham WR, Larson JL, et al. Association of neighborhood-level disadvantage with Alzheimer disease neuropathology. JAMA Netw Open. 2020;3(6):e207559. doi:
22.
Vassilaki M, Aakre JA, Castillo A, et al. Association of neighborhood socioeconomic disadvantage and cognitive impairment. Alzheimers Dement. Published online June 6, 2022. doi:
23.
Pase MP, Rowsthorn E, Cavuoto MG, et al. Association of neighborhood-level socioeconomic measures with cognition and dementia risk in Australian adults. JAMA Netw Open. 2022;5(3):e224071. doi:
24.
Weden MM, Shih RA, Kabeto MU, Langa KM. Secular trends in dementia and cognitive impairment of U.S. rural and urban older adults. Am J Prev Med. 2018;54(2):164-172. doi:
25.
Rosso AL, Flatt JD, Carlson MC, et al. Neighborhood socioeconomic status and cognitive function in late life. Am J Epidemiol. 2016;183(12):1088-1097. doi:
26.
Sheffield KM, Peek MK. Neighborhood context and cognitive decline in older Mexican Americans: results from the Hispanic Established Populations for Epidemiologic Studies of the Elderly. Am J Epidemiol. 2009;169(9):1092-1101. doi:
27.
Zeki Al Hazzouri A, Haan MN, Osypuk T, Abdou C, Hinton L, Aiello AE. Neighborhood socioeconomic context and cognitive decline among older Mexican Americans: results from the Sacramento Area Latino Study on Aging. Am J Epidemiol. 2011;174(4):423-431. doi:
28.
National Equity Atlas. PolicyLink and USC Equity Research Institute. Accessed July 15, 2022.
29.
Hall JR, Johnson LA, Zhang F, et al; HABLE Study. Using fractional anisotropy imaging to detect mild cognitive impairment and Alzheimer’s disease among Mexican Americans and non-Hispanic Whites: a HABLE study. Dement Geriatr Cogn Disord. 2021;50(3):266-273. doi:
30.
O’Bryant SE, Johnson LA, Barber RC, et al; HABLE Study Team. The Health and Aging Brain Among Latino Elders (HABLE) study methods and participant characteristics. Alzheimers Dement (Amst). 2021;13(1):e12202. doi:
31.
O’Bryant SE, Zhang F, Petersen M, et al; HABLE Study Team. A blood screening tool for detecting mild cognitive impairment and Alzheimer’s disease among community-dwelling Mexican Americans and non-Hispanic Whites: a method for increasing representation of diverse populations in clinical research. Alzheimers Dement. 2022;18(1):77-87. doi:
32.
Berg L. Clinical Dementia Rating (CDR). Psychopharmacol Bull. 1988;24(4):637-639.
33.
Wechsler D. WMS-R: Wechsler Memory Scale–Revised: Manual. Psychological Corporation; 1987.
34.
Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological Assessment. 4th ed. Oxford University Press; 2004.
35.
Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. 1st ed. Neuropsychology Press; 1985.
36.
González HM, Mungas D, Haan MN. A verbal learning and memory test for English- and Spanish-speaking older Mexican-American adults. Clin Neuropsychol. 2002;16(4):439-451. doi:
37.
O’Bryant SE, Edwards M, Johnson L, Hall J, Gamboa A, O’jile J. Texas Mexican American adult normative studies: normative data for commonly used clinical neuropsychological measures for English- and Spanish-speakers. Dev Neuropsychol. 2018;43(1):1-26. doi:
38.
Neighborhood Atlas: 2015 ADI data. Center for Health Disparities Research, University of Wisconsin School of Medicine and Public Health. Accessed May 31, 2022.
39.
Welsh-Bohmer KA, Ostbye T, Sanders L, et al; Cache Country Study Group. Neuropsychological performance in advanced age: influences of demographic factors and apolipoprotein E: findings from the Cache County Memory Study. Clin Neuropsychol. 2009;23(1):77-99. doi:
40.
Alley D, Suthers K, Crimmins E. Education and cognitive decline in older Americans: results from the AHEAD sample. Res Aging. 2007;29(1):73-94. doi:
41.
Sundermann EE, Biegon A, Rubin LH, et al; Alzheimer’s Disease Neuroimaging Initiative. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology. 2016;86(15):1368-1376. doi:
42.
Lawrence KG, Kresovich JK, O’Brien KM, et al. Association of neighborhood deprivation with epigenetic aging using 4 clock metrics. JAMA Netw Open. 2020;3(11):e2024329. doi:
43.
Byrd DA, Rivera-Mindt MG. Neuropsychology’s race problem does not begin or end with demographically adjusted norms. Nat Rev Neurol. 2022;18(3):125-126. doi:
Views 4,498
Original Investigation
Neurology
ܲܲ30, 2023

Evaluation of Neighborhood-Level Disadvantage and Cognition in Mexican American and Non-Hispanic White Adults 50 Years and Older in the US

Author Affiliations
  • 1Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada
  • 2Department of Neurosciences, University of California, San Diego, La Jolla
  • 3Veterans Affairs San Diego Healthcare System, San Diego, California
  • 4Alzheimer’s Therapeutic Research Institute, University of Southern California, San Diego
  • 5Institute for Translational Research, University of North Texas Health Science Center, Fort Worth
  • 6Department of Family Medicine, University of North Texas Health Science Center, Fort Worth
  • 7Department of Psychiatry, Neurology, and Epidemiology and Biostatistics, University of California, San Francisco
  • 8San Francisco VA Medical Center, San Francisco, California
  • 9Center for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison
  • 10Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison
JAMA Netw Open. 2023;6(8):e2325325. doi:10.1001/jamanetworkopen.2023.25325
Key Points

Question Is neighborhood disadvantage associated with cognitive performance among older Mexican American and non-Hispanic White adults?

Findings In this cross-sectional study of 1614 participants (853 Mexican American and 761 non-Hispanic White) 50 years and older from the Health and Aging Brain Study–Health Disparities, living in a more disadvantaged neighborhood was associated with worse performance across several cognitive domains among Mexican American adults and worse performance on aspects of memory and processing speed among non-Hispanic White adults.

Meaning These findings suggest that understanding and addressing contextual social determinants of health associated with cognition will be important for improving aging outcomes, particularly among racial and ethnic minority populations.

Abstract

Importance Understanding how socioeconomic factors are associated with cognitive aging is important for addressing health disparities in Alzheimer disease.

Objective To examine the association of neighborhood disadvantage with cognition among a multiethnic cohort of older adults.

Design, Setting, and Participants In this cross-sectional study, data were collected between September 1, 2017, and May 31, 2022. Participants were from the Health and Aging Brain Study–Health Disparities, which is a community-based single-center study in the Dallas/Fort Worth area of Texas. A total of 1614 Mexican American and non-Hispanic White adults 50 years and older were included.

Exposure Neighborhood disadvantage for participants’ current residence was measured by the validated Area Deprivation Index (ADI); ADI Texas state deciles were converted to quintiles, with quintile 1 representing the least disadvantaged area and quintile 5 the most disadvantaged area. Covariates included age, sex, and educational level.

Main Outcomes and Measures Performance on cognitive tests assessing memory, language, attention, processing speed, and executive functioning; measures included the Spanish-English Verbal Learning Test (SEVLT) Learning and Delayed Recall subscales; Wechsler Memory Scale, third edition (WMS-III) Digit Span Forward, Digit Span Backward, and Logical Memory 1 and 2 subscales; Trail Making Test (TMT) parts A and B; Digit Symbol Substitution Test (DSST); Letter Fluency; and Animal Naming. Raw scores were used for analyses. Associations between neighborhood disadvantage and neuropsychological performance were examined via demographically adjusted linear regression models stratified by ethnic group.

Results Among 1614 older adults (mean [SD] age, 66.3 [8.7] years; 980 women [60.7%]), 853 were Mexican American (mean [SD] age, 63.9 [7.9] years; 566 women [66.4%]), and 761 were non-Hispanic White (mean [SD] age, 69.1 [8.7] years; 414 women [54.4%]). Older Mexican American adults were more likely to reside in the most disadvantaged areas (ADI quintiles 3-5), with 280 individuals (32.8%) living in ADI quintile 5, whereas a large proportion of older non-Hispanic White adults resided in ADI quintile 1 (296 individuals [38.9%]). Mexican American individuals living in more disadvantaged areas had worse performance than those living in ADI quintile 1 on 7 of 11 cognitive tests, including SEVLT Learning (ADI quintile 5: β = −2.50; 95% CI, −4.46 to –0.54), SEVLT Delayed Recall (eg, ADI quintile 3: β = −1.11; 95% CI, −1.97 to –0.24), WMS-III Digit Span Forward (eg, ADI quintile 4: β = −1.14; 95% CI, −1.60 to –0.67), TMT part A (ADI quintile 5: β = 7.85; 95% CI, 1.28-14.42), TMT part B (eg, ADI quintile 5: β = 31.5; 95% CI, 12.16-51.35), Letter Fluency (ADI quintile 4: β = −2.91; 95% CI, −5.39 to −0.43), and DSST (eg, ADI quintile 5: β = −4.45; 95% CI, −6.77 to –2.14). In contrast, only non-Hispanic White individuals living in ADI quintile 4 had worse performance than those living in ADI quintile 1 on 4 of 11 cognitive tests, including SEVLT Learning (β = −2.35; 95% CI, −4.40 to –0.30), SEVLT Delayed Recall (β = −0.95; 95% CI, −1.73 to –0.17), TMT part B (β = 15.95; 95% CI, 2.47-29.44), and DSST (β = −3.96; 95% CI, −6.49 to –1.43).

Conclusions and Relevance In this cross-sectional study, aging in a disadvantaged area was associated with worse cognitive functioning, particularly for older Mexican American adults. Future studies examining the implications of exposure to neighborhood disadvantage across the life span will be important for improving cognitive outcomes in diverse populations.

Introduction

Alzheimer disease (AD) disproportionately impacts older African American and Hispanic adults in the US.1 Older African American individuals currently experience the highest burden of AD, while older Hispanic individuals (65% of whom identify as Mexican American)2 are estimated to have the greatest increase in AD by 2060.1 Despite cognitive health disparities and projections of increasing racial and ethnic diversity in the US, Hispanic individuals are underrepresented in AD research.3 To develop advancements in AD prevention and treatment among diverse populations, this gap must be addressed.

The fundamental causes theory proposes that effective interventions for reducing health disparities require understanding of the distal (ie, fundamental) forces, such as socioeconomic context, that put people at “risk for (more proximal) risks,”4 such as individual-level income, educational level, and health behaviors. Previous research has found that these individual factors are associated with AD risk and play a role in health disparities in dementia prevalence.5 Although there is a growing body of literature pertaining to contextual-level social determinants of health, such as neighborhood disadvantage (ND), which is associated with structural and systematic inequities,6,7 less is known about the association of these factors with brain aging, especially for those with diverse backgrounds.

Living in a socioeconomically disadvantaged neighborhood increases the risk of poor health outcomes.8-11 For example, greater ND has been associated with increased cardiovascular disease–specific morbidity and mortality,12,13 and these increases are more pronounced for those with minority racial and ethnic backgrounds, such as African American individuals compared with non-Hispanic White individuals,14,15 suggesting that ND may be a key factor in health disparities. Greater ND may similarly confer increased risk of AD, especially among diverse communities.16

One validated measure of ND is the Area Deprivation Index (ADI), which uses 17 US Census and American Community Survey indicators of poverty, education, housing, and employment to characterize the level of disadvantage within Census block groups.10,17,18 The ADI has been associated with several AD-relevant factors by Kind et al.17-21 Examining cognitively unimpaired participants in the Wisconsin Registry for Alzheimer’s Prevention Study, Hunt et al19 found that living in the most disadvantaged neighborhoods was associated with greater cognitive decline and cortical thinning in AD signature regions. Moreover, these results remained significant for all but 1 region after accounting for racial and demographic differences between areas of high and low disadvantage.19 The same group also found lower hippocampal and total brain volumes among participants living in the most disadvantaged neighborhoods, even after accounting for differences in individual-level socioeconomic status.20 Furthermore, residing in areas of higher ND has been associated with increased odds of AD neuropathology.21 Other studies22,23 have confirmed these findings.

Of the limited studies examining ND and cognitive outcomes, few have focused on diverse populations.3 Some evidence suggests the association of neighborhood context with cognition may vary by race.24,25 For example, Rosso et al25 found greater differences in baseline cognitive performance between neighborhoods with high and low socioeconomic status for African American individuals compared with non-Hispanic White individuals. One study26 found that ND was associated with cognitive decline among older Mexican American adults, although other studies25,27 have not found a longitudinal association between neighborhood context and cognition. Notably, these studies24-27 examining neighborhood context and cognition in diverse cohorts used their own individually developed measures to capture ND, which may explain some of the discrepancies between studies. Methodological differences aside, accumulating evidence suggests that neighborhood context can play a role in cognition and that these cognitive outcomes may differ depending on race and ethnicity.

Due to legacies of structural inequalities, Hispanic individuals disproportionately reside in high-poverty US neighborhoods,28 which may be an important factor underlying the disproportionate increase in AD projected for the Hispanic American population. The primary aim of this study was to further our understanding of the association between ND and cognitive functioning among older Mexican American adults compared with older non-Hispanic White adults. We hypothesized that not only would greater ND be associated with worse cognitive functioning, but this worse functioning would be more pronounced for Mexican American individuals than non-Hispanic White individuals.

Methods
Participants

Data for this cross-sectional study were obtained from the Health and Aging Brain Study–Health Disparities (HABS-HD) study (formerly the Health and Aging Brain Among Latino Elders [HABLE] study), a longitudinal community-based study examining health disparities in mild cognitive impairment and dementia among Mexican American individuals compared with non-Hispanic White individuals.29-31 The HABS-HD study methods have been published elsewhere.30 The HABS-HD study is a single-site project, and participants were recruited from the Dallas/Fort Worth metropolitan area of Texas using community-based participatory research methods. The HABS-HD study was approved by the institutional review board of the University of North Texas Health Science Center. Each participant (or their legal representative) provided written informed consent, including consent to use and publish their data in future studies. The current study used baseline data from Mexican American and non-Hispanic White individuals 50 years and older who participated in the HABS-HD study from September 1, 2017, through May 31, 2022. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology () reporting guideline for cross-sectional studies.

Procedures

All aspects of the HABS-HD study protocol were conducted in Spanish or English according to participant preference. An interview was conducted, during which data on self-reported race and ethnicity, educational level, sex, annual household income, and current residence were collected. An informant interview by clinicians with expertise in dementia was also conducted using the Clinical Dementia Rating scale32 to evaluate functional decline. Data from the Clinical Dementia Rating scale, self- and informant-reported daily function, and neuropsychological testing results were reviewed via consensus conference (including J.R.H., M.P., and S.E.O.) to determine 1 of 3 clinical diagnoses: normal control, mild cognitive impairment, or dementia. As of June 6, 2022, a total of 1614 participants (853 Mexican American and 761 non-Hispanic White individuals) underwent consensus review and had requisite data available for geocoding and ADI linkage.

Neuropsychological Assessment

Participants completed a battery of neuropsychological tests. Raw scores from the primary indices of cognitive measures were used in analyses, resulting in 11 total outcomes. Cognitive measures included the Wechsler Memory Scale, third edition (WMS-III) Digit Span Forward subscale (range, 0-16, with higher scores indicating better attention performance), WMS-III Digit Span Backward subscale (range, 0-14, with higher scores indicating better working memory performance), WMS-III Logical Memory 1 subscale (range, 0-75, with higher scores indicating better immediate story recall performance),33 WMS-III Logical Memory 2 subscale (range, 0-50, with higher scores indicating better delayed story recall performance), Digit Symbol Substitution Test (DSST; range, 0-93, with higher scores indicating better processing speed performance),34 Trail Making Test (TMT) parts A and B (scored by length of time [up to 180 seconds for part A and 300 seconds for part B] taken to complete the test, with longer times indicating worse processing speed [part A] or worse executive functioning [part B] performance),35 Spanish-English Verbal Learning Test (SEVLT) Learning subscale (range, 0-60, with higher scores indicating better word list learning performance), SEVLT Delayed Recall subscale (range, 0-15, with higher scores indicating better delayed word list learning performance),36 Animal Naming (scored by number of animal names verbalized within 60 seconds, with higher numbers indicating better semantic fluency performance),34 and Letter Fluency (FAS; scored by number of words beginning with F, A, and S verbalized within 60 seconds, with higher numbers indicating better phonemic fluency performance).37 Histograms of the cognitive data and frequency of missing data for each variable are shown in eFigures 1 and 2 in Supplement 1.

Area Deprivation Index

Neighborhood disadvantage was measured by the ADI, which has been made freely available to the public by the University of Wisconsin via the Neighborhood Atlas.10,17,38 Each participant’s current residence was geocoded and linked to 2019 ADI scores. For this study, Texas state decile ranks for ADIs were used, which were collapsed into quintiles to reduce the number of comparisons required, with quintile 1 representing the least disadvantaged areas and quintile 5 representing the most disadvantaged areas.

Statistical Analysis

Statistical analyses were conducted using IBM SPSS Statistics software, version 23 (IBM Corporation). Associations between ADI and cognition were evaluated using separate linear regression models for each cognitive variable, adjusting for group differences in demographic characteristics known to alter cognition, including age, sex, and educational level. The linear regression models were stratified by ethnic group (ie, run separately for older Mexican American and older non-Hispanic White adults). The ADI quintiles were dummy coded, using ADI quintile 1 as the referent, to allow for representation of each quintile group within the regression models. Inverse probability weights (IPWs) were estimated using the ipw package, version 1.2, in R software, version 4.3.0 (R Foundation for Statistical Computing), to address missing cognitive data, then included as weights in the linear regression models. Tests were 2-tailed, and statistical significance was set at 2-tailed P < .05 for all analyses, without adjustment for multiple comparisons given the preliminary nature of this investigation. Results were expressed as means with SDs and regression coefficients (β estimates) with corresponding 95% CIs.

Results

From September 2017 through May 2022, 1614 individuals (mean [SD] age, 66.3 [8.7] years; 980 women [60.7%] and 634 men [39.3%]) participated in the HABS-HD study and had available ADI data. Of those, 853 participants (52.9%) were Mexican American (mean [SD] age, 63.9 [7.9] years; 566 women [66.4%] and 287 men [33.6%]), and 761 (47.1%) were non-Hispanic White (mean [SD] age, 69.1 [8.7] years; 414 women [54.4%] and 347 men [45.6%]). Among Mexican American participants, 71 (8.3%) lived in ADI quintile 1 (least disadvantaged area), 106 (12.4%) in quintile 2, 132 (15.5%) in quintile 3, 264 (30.9%) in quintile 4, and 280 (32.8%) in quintile 5 (most disadvantaged area). Among non-Hispanic White participants, 296 (38.9%) lived in ADI quintile 1, 235 (30.9%) in quintile 2, 119 (15.6%) in quintile 3, 85 (11.2%) in quintile 4, and 26 (3.4%) in quintile 5. Overall, 80 Mexican American participants (9.4%) had a dementia diagnosis (4 individuals in ADI quintile 1, 5 in quintile 2, 5 in quintile 3, 40 in quintile 4, and 26 in quintile 5) compared with 46 non-Hispanic White participants (6.0%; 16 individuals in ADI quintile 1, 16 in quintile 2, 8 in quintile 3, 6 in quintile 4, and 0 in quintile 5). Additional demographic and clinical characteristics for both ethnic groups by ADI quintile are shown in Table 1.

In demographically adjusted linear regression models, older Mexican American adults residing in ADI quintile 1 had better performance than those residing in more disadvantaged ADI quintiles (ie, quintiles 3-5) on 7 of 11 cognitive measures, including SEVLT Learning (ADI quintile 5: β = −2.50 [95% CI, −4.46 to –0.54]), SEVLT Delayed Recall (ADI quintile 3: β = −1.11 [95% CI, −1.97 to –0.24]; ADI quintile 4: β = −1.05 [95% CI, −1.85 to –0.25]; ADI quintile 5: β = −0.97 [95% CI, −1.78 to –0.16]), WMS-III Digit Span Forward (ADI quintile 3: β = −1.09 [95% CI, −1.60 to –0.59]; ADI quintile 4: β = −1.14 [95% CI, −1.60 to –0.67]; ADI quintile 5: β = −1.07 [95% CI, −1.54 to –0.59]), TMT part A (ADI quintile 5: β = 7.85; 95% CI, 1.28-14.42), TMT part B (ADI quintile 4: β = 26.17 [95% CI, 6.85-45.48]; ADI quintile 5: β = 31.75 [95% CI, 12.16-51.35]), FAS (ADI quintile 4: β = −0.12; 95% CI, −5.39 to −0.43), and DSST (ADI quintile 3: β = −3.73 [95% CI, −6.20 to –1.26]; ADI quintile 4: β = −4.44 [95% CI, −6.72 to –2.16]; ADI quintile 5: β = −4.45 [95% CI, −6.77 to –2.14]) (Table 2). No significant differences in cognition were found between older Mexican American adults living in ADI quintile 2 vs quintile 1.

Older non-Hispanic White adults residing in ADI quintile 1 had better performance than their counterparts residing in ADI quintile 4 on 4 of 11 cognitive measures, including SEVLT Learning (β = −2.35; 95% CI, −4.40 to –0.30), SEVLT Delayed Recall (β = −0.95; 95% CI, −1.73 to –0.17), TMT part B (β = 15.95; 95% CI, 2.47-29.44), and DSST (β = −3.96; 95% CI, −6.49 to –1.43) (Table 3). No significant differences in cognitive performance were found between older non-Hispanic White adults living in ADI quintiles 2, 3, or 5 vs quintile 1.

Discussion

To our knowledge, this cross-sectional study reflects one of the largest examinations of neighborhood context and neuropsychological functioning among a community-based multiethnic cohort of older adults. Our findings revealed an association between higher neighborhood-level disadvantage (ADI quintiles 3-5) and worse performance on tests of memory, attention, processing speed, and executive functioning among older Mexican American adults after controlling for individual-level demographic factors. In contrast, only older non-Hispanic White adults living in ADI quintile 4 had worse performance than their counterparts living in ADI quintile 1 on 4 measures (SEVLT Learning, SELVT Delayed Recall, TMT part B, and DSST). These findings were consistent with previous research24,25 revealing the association between neighborhood context and cognition may vary by racial and ethnic background. However, another study19 found that the association between ND and significant cognitive decline remained after accounting for race.

Differences between levels of ND in these areas of cognition (and in some cases, the same tests) have been found in previous studies,19,25 suggesting that these cognitive areas may be particularly sensitive to the consequences of contextual-level social determinants of health. For example, in the current study, ND was associated with the DSST, a measure of processing speed, in both ethnic groups, and several measures associated with ADI quintile in the Mexican American group involved a speed component (eg, FAS and TMT parts A and B). Processing speed can be altered by different conditions, including vascular disease, which may be disproportionately impacted by ND in racial and ethnic minority groups.15 Nevertheless, ADI was not associated with all measures of processing speed, and additional research examining which cognitive domains are most often associated with ND is needed.

Reasons for the differential association of ND with cognition among older Mexican American and non-Hispanic White adults are not fully understood. There is likely an interplay of individual, sociopolitical, and environmental factors, which may have a role in how ND is associated with cognition among different racial and ethnic groups. For example, the potential negative implications of ND for health outcomes may be compounded by perceived discrimination and housing discrimination experienced by individuals from marginalized groups. Furthermore, non-Hispanic White adults living in disadvantaged areas may have more opportunities for upward mobility due to fewer barriers related to educational level and employment, which could result in moving out of disadvantaged areas at higher rates compared with individuals from ethnically and racially diverse backgrounds. The linear regression models examining ADI and cognition were adjusted for individual-level demographic factors known to be associated with cognition (ie, age, sex, and educational level),39-41 but there may be other factors relevant to cognition that were not included in the analyses. Thus, although ADI may capture distinct contextual-level information that can have implications for cognition, there is still heterogeneity within similarly disadvantaged neighborhoods by ethnic group, likely reflective of US structural inequities. Research examining exposure to ND over the life course among different racial and ethnic groups is needed.

There are many potential mechanistic pathways for ND to impact cognitive aging across the life span. Lawrence et al42 examined epigenetic aging among 2630 women living in the US and Puerto Rico and reported that those with the highest ND (>75th percentile) vs the lowest ND (≤25th percentile) had higher epigenetic age acceleration as estimated by 3 of 4 epigenetic clocks. The HABS-HD study currently captures broad-based multilevel omics (ie, the structure and function of the whole makeup of a biological function at different levels) and imaging data; therefore, additional work is ongoing to more deeply explore biological and sociocultural mechanistic pathways for the association between neighborhood-level disadvantage and brain aging.

Notably, when compared with those living in the most advantaged neighborhoods (ie, ADI quintile 1), there were only significant differences in cognitive performance for individuals living in areas below the ADI quintile 2; both Mexican American and non-Hispanic White participants living in quintile 2 had cognitive performance similar to those living in the quintile 1. For older Mexican American adults, we found a broader range of ADI quintiles with worse cognitive performance compared with the most advantaged areas than previous research,19 which only found baseline differences in ADI quintiles 4 and 5 compared with ADI quintile 1. Although more research is needed to identify the specific communities at risk of adverse cognitive outcomes, evaluating and addressing the factors associated with health disparities in these less advantaged areas (ie, ADI quintiles 3-5) may be beneficial, especially among racial and ethnic minority individuals. These findings also support the notion that context-related risk of cognitive decline does not occur only among those living in the most disadvantaged areas; neighborhoods that have a moderate disadvantage are also in need of resources to address health risks. This issue is particularly important because ND is a fundamentally modifiable factor that is impacted through social policy and community intervention.

Limitations

This study has limitations. First, the current analyses are cross-sectional. However, the HABS-HD study is longitudinal, and follow-up analyses over time will be conducted after visit 2 assessments have been completed. Second, the number of non-Hispanic White participants residing in the most disadvantaged neighborhoods was small (26 participants in ADI quintile 5), and there were no non-Hispanic White individuals classified as having dementia in ADI quintile 5, which may have had implications for results revealing a lack of a dose-response association between ADI quintile and cognition in the non-Hispanic White group (ie, there were significant differences between ADI quintiles 1 and 4 but not between ADI quintiles 1 and 5). Third, as with most studies examining cognitive aging, there were missing outcome data. Although adjustments were made to address missing data using IPW in analyses, the assumption that data were missing at random may have been violated because some missing data may be associated with more impaired participants not being able to complete the full neuropsychological battery. Fourth, because this cohort was from Texas, socioeconomic disadvantage at the state level (ie, Texas state ADI deciles) was used, which may limit generalizability to populations outside of Texas. Fifth, although not necessarily a limitation, these findings are specific to older Mexican American vs non-Hispanic White adults and cannot be generalized to other racial and ethnic minority groups. The HABS-HD study is currently enrolling a comparable cohort of older African American adults, which will facilitate similar research across the 3 largest racial and ethnic groups in the US.

Conclusions

Overall, this cross-sectional study represents an important and novel contribution to the AD literature and allows for investigation of the specific implications of individual- and contextual-level disadvantage factors. The study’s findings revealed that aging in a disadvantaged neighborhood is associated with worse cognitive functioning, particularly for older Mexican American adults. In addition to individual demographic factors, neighborhood-level disadvantage accounted for some differences in neuropsychological performance between Mexican American and non-Hispanic White groups. Because race and ethnicity are sociocultural constructs that serve as proxies for other factors that directly play a role in cognitive health disparities,43 continuing to understand both individual and contextual factors will be important for improving aging outcomes among diverse populations.

Back to top
Article Information

Accepted for Publication: June 12, 2023.

Published: August 30, 2023. doi:10.1001/jamanetworkopen.2023.25325

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2023 Wong CG et al. vlog Open.

Corresponding Author: Christina G. Wong, PhD, Cleveland Clinic Lou Ruvo Center for Brain Health, 888 W Bonneville Ave, Las Vegas, NV 89135 (cgwong23@gmail.com).

Author Contributions: Drs Wong and Miller had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Rissman, Petersen, Kind, ’BⲹԳ.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Wong, Miller, Rissman, Petersen, ’BⲹԳ.

Critical review of the manuscript for important intellectual content: Miller, Zhang, Rissman, Raman, Hall, Petersen, Yaffe, Kind, ’BⲹԳ.

Statistical analysis: Wong, Miller, Zhang.

Obtained funding: Yaffe, Kind, ’BⲹԳ.

Administrative, technical, or material support: Rissman, Hall, Petersen, Kind, ’BⲹԳ.

Supervision: ’BⲹԳ.

Conflict of Interest Disclosures: Dr Raman reported receiving grants from the National Institute on Aging (NIA) during the conduct of the study and grants from the Alzheimer’s Association, the American Heart Association, Eisai Co, and Eli Lilly and Company outside the submitted work. Dr Yaffe reported receiving personal fees from Alector, Alpha Cognition, and Eli Lilly and Company; and service duties on data safety monitoring boards for National Institutes of Health–sponsored studies outside the submitted work. Dr Kind reported receiving grants from the National Institutes of Health during the conduct of the study and outside the submitted work. Dr O’Bryant reported receiving personal fees from Cx Precision Medicine, owning multiple patents on precision medicine for neurodegenerative diseases that have been licensed to Cx Precision Medicine, and serving on advisory boards for Eisai Co outside the submitted work. No other disclosures were reported.

Funding/Support: This study was supported by grants R01AG054073, R01AG058533, and U19AG078109 (Dr O’Bryant); grant P20 AG068053 from the Nevada Exploratory Alzheimer’s Disease Research Center (Drs Wong and Miller), grant P20 GM109025 from the National Institute of Graduate Medical Studies (Drs Wong and Miller), and funding from Keep Memory Alive (Dr Miller). The Area Deprivation Index and Neighborhood Atlas are supported by grants R01 AG070883 and RF1AG057784 from the NIA (Dr Kind).

Role of the Funder/Sponsor: The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Group Information: Members of the HABS-HD Study Team are provided in Supplement 2.

Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Data Sharing Statement: See Supplement 3.

References
1.
Matthews KA, Xu W, Gaglioti AH, et al. Racial and ethnic estimates of Alzheimer’s disease and related dementias in the United States (2015-2060) in adults aged ≥65 years. Alzheimers Dement. 2019;15(1):17-24. doi:
2.
QuickFacts. United States Census Bureau; 2020. Accessed February 16, 2022.
3.
Babulal GM, Quiroz YT, Albensi BC, et al; International Society to Advance Alzheimer’s Research and Treatment, Alzheimer’s Association. Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: update and areas of immediate need. Alzheimers Dement. 2019;15(2):292-312. doi:
4.
Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995:80-94. doi:
5.
Vega IE, Cabrera LY, Wygant CM, Velez-Ortiz D, Counts SE. Alzheimer’s disease in the Latino community: intersection of genetics and social determinants of health. J Alzheimers Dis. 2017;58(4):979-992. doi:
6.
Alson JG, Robinson WR, Pittman L, Doll KM. Incorporating measures of structural racism into population studies of reproductive health in the United States: a narrative review. Health Equity. 2021;5(1):49-58. doi:
7.
Erikson CE, Dent RB, Park YH, Luo Q. Historic redlining and contemporary behavioral health workforce disparities. JAMA Netw Open. 2022;5(4):e229494. doi:
8.
Johnson AE, Zhu J, Garrard W, et al. Area Deprivation Index and cardiac readmissions: evaluating risk-prediction in an electronic health record. J Am Heart Assoc. 2021;10(13):e020466. doi:
9.
Kitchen C, Hatef E, Chang HY, Weiner JP, Kharrazi H. Assessing the association between Area Deprivation Index on COVID-19 prevalence: a contrast between rural and urban U.S. jurisdictions. AIMS Public Health. 2021;8(3):519-530. doi:
10.
Singh GK. Area deprivation and widening inequalities in US mortality, 1969-1998. Am J Public Health. 2003;93(7):1137-1143. doi:
11.
Zuelsdorff M, Larson JL, Hunt JFV, et al. The Area Deprivation Index: a novel tool for harmonizable risk assessment in Alzheimer’s disease research. Alzheimers Dement (N Y). 2020;6(1):e12039. doi:
12.
Gaglioti AH, Xu J, Rollins L, et al. Neighborhood environmental health and premature death from cardiovascular disease. Prev Chronic Dis. 2018;15:E17. doi:
13.
Diez Roux AV, Mujahid MS, Hirsch JA, Moore K, Moore LV. The impact of neighborhoods on CV risk. Glob Heart. 2016;11(3):353-363. doi:
14.
Barber S, Hickson DA, Wang X, Sims M, Nelson C, Diez-Roux AV. Neighborhood disadvantage, poor social conditions, and cardiovascular disease incidence among African American adults in the Jackson Heart Study. Am J Public Health. 2016;106(12):2219-2226. doi:
15.
Xiao YYK, Graham G. Where we live: the impact of neighborhoods and community factors on cardiovascular health in the United States. Clin Cardiol. 2019;42(1):184-189. doi:
16.
Yaffe K, Falvey C, Harris TB, et al; Health ABC Study. Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study. Ѵ. 2013;347:f7051. doi:
17.
Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible—the Neighborhood Atlas. N Engl J Med. 2018;378(26):2456-2458. doi:
18.
Kind AJH, Jencks S, Brock J, et al. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med. 2014;161(11):765-774. doi:
19.
Hunt JFV, Vogt NM, Jonaitis EM, et al. Association of neighborhood context, cognitive decline, and cortical change in an unimpaired cohort. ܰDZDz. 2021;96(20):e2500-e2512. doi:
20.
Hunt JFV, Buckingham W, Kim AJ, et al. Association of neighborhood-level disadvantage with cerebral and hippocampal volume. JAMA Neurol. 2020;77(4):451-460. doi:
21.
Powell WR, Buckingham WR, Larson JL, et al. Association of neighborhood-level disadvantage with Alzheimer disease neuropathology. JAMA Netw Open. 2020;3(6):e207559. doi:
22.
Vassilaki M, Aakre JA, Castillo A, et al. Association of neighborhood socioeconomic disadvantage and cognitive impairment. Alzheimers Dement. Published online June 6, 2022. doi:
23.
Pase MP, Rowsthorn E, Cavuoto MG, et al. Association of neighborhood-level socioeconomic measures with cognition and dementia risk in Australian adults. JAMA Netw Open. 2022;5(3):e224071. doi:
24.
Weden MM, Shih RA, Kabeto MU, Langa KM. Secular trends in dementia and cognitive impairment of U.S. rural and urban older adults. Am J Prev Med. 2018;54(2):164-172. doi:
25.
Rosso AL, Flatt JD, Carlson MC, et al. Neighborhood socioeconomic status and cognitive function in late life. Am J Epidemiol. 2016;183(12):1088-1097. doi:
26.
Sheffield KM, Peek MK. Neighborhood context and cognitive decline in older Mexican Americans: results from the Hispanic Established Populations for Epidemiologic Studies of the Elderly. Am J Epidemiol. 2009;169(9):1092-1101. doi:
27.
Zeki Al Hazzouri A, Haan MN, Osypuk T, Abdou C, Hinton L, Aiello AE. Neighborhood socioeconomic context and cognitive decline among older Mexican Americans: results from the Sacramento Area Latino Study on Aging. Am J Epidemiol. 2011;174(4):423-431. doi:
28.
National Equity Atlas. PolicyLink and USC Equity Research Institute. Accessed July 15, 2022.
29.
Hall JR, Johnson LA, Zhang F, et al; HABLE Study. Using fractional anisotropy imaging to detect mild cognitive impairment and Alzheimer’s disease among Mexican Americans and non-Hispanic Whites: a HABLE study. Dement Geriatr Cogn Disord. 2021;50(3):266-273. doi:
30.
O’Bryant SE, Johnson LA, Barber RC, et al; HABLE Study Team. The Health and Aging Brain Among Latino Elders (HABLE) study methods and participant characteristics. Alzheimers Dement (Amst). 2021;13(1):e12202. doi:
31.
O’Bryant SE, Zhang F, Petersen M, et al; HABLE Study Team. A blood screening tool for detecting mild cognitive impairment and Alzheimer’s disease among community-dwelling Mexican Americans and non-Hispanic Whites: a method for increasing representation of diverse populations in clinical research. Alzheimers Dement. 2022;18(1):77-87. doi:
32.
Berg L. Clinical Dementia Rating (CDR). Psychopharmacol Bull. 1988;24(4):637-639.
33.
Wechsler D. WMS-R: Wechsler Memory Scale–Revised: Manual. Psychological Corporation; 1987.
34.
Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological Assessment. 4th ed. Oxford University Press; 2004.
35.
Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. 1st ed. Neuropsychology Press; 1985.
36.
González HM, Mungas D, Haan MN. A verbal learning and memory test for English- and Spanish-speaking older Mexican-American adults. Clin Neuropsychol. 2002;16(4):439-451. doi:
37.
O’Bryant SE, Edwards M, Johnson L, Hall J, Gamboa A, O’jile J. Texas Mexican American adult normative studies: normative data for commonly used clinical neuropsychological measures for English- and Spanish-speakers. Dev Neuropsychol. 2018;43(1):1-26. doi:
38.
Neighborhood Atlas: 2015 ADI data. Center for Health Disparities Research, University of Wisconsin School of Medicine and Public Health. Accessed May 31, 2022.
39.
Welsh-Bohmer KA, Ostbye T, Sanders L, et al; Cache Country Study Group. Neuropsychological performance in advanced age: influences of demographic factors and apolipoprotein E: findings from the Cache County Memory Study. Clin Neuropsychol. 2009;23(1):77-99. doi:
40.
Alley D, Suthers K, Crimmins E. Education and cognitive decline in older Americans: results from the AHEAD sample. Res Aging. 2007;29(1):73-94. doi:
41.
Sundermann EE, Biegon A, Rubin LH, et al; Alzheimer’s Disease Neuroimaging Initiative. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology. 2016;86(15):1368-1376. doi:
42.
Lawrence KG, Kresovich JK, O’Brien KM, et al. Association of neighborhood deprivation with epigenetic aging using 4 clock metrics. JAMA Netw Open. 2020;3(11):e2024329. doi:
43.
Byrd DA, Rivera-Mindt MG. Neuropsychology’s race problem does not begin or end with demographically adjusted norms. Nat Rev Neurol. 2022;18(3):125-126. doi:
×